Despite these advancements, MM remains generally incurable and no standard cure is currently available for patients with r/r MM previously treated with multiple regimens including proteasome inhibitors, IMiDs, and anti‐CD38 monoclonal antibodies. The gene discussed is CD38; the disease is Miyoshi myopathy.